Receives CE Marking

Related by string. * RECEIVES . receives . RECEIVE . re ceive . receive : RECEIVE AN E MAIL . Iron Consulting receives . Parents Receive Graphic . Receive mediabistro.com s . receive Townhall.com delivered / CEs . ces . Ces . CEED . Ce : dans ce . dans ces . resour ces . pri ces . sour ces / marked . marking . mark . marks : By MARK LONG . spokesman Mark Regev . Mark Zandi chief . CEO Mark Zuckerberg * *

Related by context. Frequent words. (Click for all words.) 81 Announces FDA Clearance 77 Receives Orphan Drug Designation 76 FDA Clears 75 Provides Shareholder 75 Receives CE 75 Initiates Phase II 74 FDA Accepts 74 Completes Enrollment 73 Receives Patent 73 Flagship Product 73 Announces Immediate Availability 73 Receives FDA Clearance 73 Introduces Enhanced 73 Introduces Revolutionary 73 Patient Enrollment 73 Q1 Loss Narrows 73 Announces Stockholder Approval 73 Delivers Next Generation 73 Achieves Milestone 72 Strengthens Leadership 72 MITTEILUNG UEBERMITTELT VON BUSINESS 72 Files Shelf Registration Statement 72 Provide Comprehensive 72 Q2 Loss Narrows 72 Releases Enhanced 72 Develop Novel 72 Attains Gold Certified Partner 72 Receives Certification 72 Presents Positive 71 Increases Share Repurchase 71 Regains Compliance With 71 Awarded Patent 71 Meets Primary Endpoint 71 AXYS Design Automation 71 Files Patent Infringement 71 Announces Enhancements 71 Regains Compliance 71 Q2 Loss Widens 71 Unveils Enhanced 71 Vovici Online Survey 71 Q3 Loss Narrows 71 Secures Financing 71 Completes Tender Offer 71 Announces Additions 70 Q3 Loss Widens 70 Develop Next Generation 70 Introduces Next Generation 70 Announces Organizational Changes 70 Receives Notification 70 Commences Phase 70 Updates Guidance 70 Announces Definitive Agreement 70 Inc Therapeutic Competitors 70 Launches Next Generation 70 Vertex Pharmaceuticals Announces 70 Improves Survival 70 Finalizes Acquisition 70 Provides Comprehensive 70 Inhaled Insulin 70 Significantly Improves 69 Regulatory Disclosure 69 Annual Meeting Date 69 FDA Clearance 69 Launches Enhanced 69 Receives Positive 69 Patent Issued 69 Launches Unique 69 Reports Profitable 69 Q4 Loss Narrows 69 Shareholders Approve Acquisition 69 Explore Strategic Alternatives 69 Awarded Multi 69 Announces Initiation 69 Receives Regulatory 69 Schedules Fiscal 69 Stockholders Approve Merger 69 Provides Guidance 69 Completes Financing 69 Announces Stock Repurchase 69 Drug Candidate 69 Reduces Risk 69 Formalizes 69 Natural Catastrophe Stress 69 Phase III Clinical Trial 69 Announces Dismissal 69 Announces Successful Completion 69 Unveils Next Generation 69 Q4 Loss Widens 69 Clinical Trial Results 69 Internationally Recognized 69 Files Patent 69 Unveils Innovative 69 Complete Merger 69 Signs Reseller Agreement 68 Issues Guidance 68 Significantly Reduces 68 By Katey Rich 68 Secures Additional 68 Delivers Enhanced 68 Non Invasive 68 Inovio Pharmaceuticals

Back to home page